Market Overview The India GLP-1 Receptor Agonist Market is valued at USD 82.2 million in 2024 with an approximated compound annual growth rate (CAGR) of 24.6% from 2024-2030, based on a comprehensive analysis approved by leading health organizations and market research firms
9 GLP-1RAs should not be prescribed in patients with a history of pancreatitis, a personal or family history of medullary thyroid cancer, or multiple endocrine neoplasia due to the observed development of thyroid tumors in animal studies
ConsumerLab Tests Reveal Amounts of Fulvic Acid & Heavy Metals White Plains, NY, September 26, 2024 -- Shilajit is a tar-like substance created by decomposed plant material and found in mountain rocks
This review examines the main effects of GLP-1 and its analogs, GLP-1RA, on the body, with a focus on the brain mechanisms mediated by the GLP-1R, which form the basis for using these compounds to treat brain diseases and comorbidities
The electrostatic attraction between positively charged chitosan and negatively charged surface of PLGA-based NPs was also exploited by the group of Qian et al
15 May 2020